182 related articles for article (PubMed ID: 23499861)
1. Characterization of a novel merozoite surface protein of Plasmodium vivax, Pv41.
Cheng Y; Lu F; Tsuboi T; Han ET
Acta Trop; 2013 Jun; 126(3):222-8. PubMed ID: 23499861
[TBL] [Abstract][Full Text] [Related]
2. Identification of a novel merozoite surface antigen of Plasmodium vivax, PvMSA180.
Muh F; Han JH; Nyunt MH; Lee SK; Jeon HY; Ha KS; Park WS; Hong SH; Ahmed MA; Na S; Takashima E; Tsuboi T; Han ET
Malar J; 2017 Mar; 16(1):133. PubMed ID: 28351409
[TBL] [Abstract][Full Text] [Related]
3. Characterization of Pv92, a Novel Merozoite Surface Protein of Plasmodium vivax.
Lee SK; Wang B; Han JH; Nyunt MH; Muh F; Chootong P; Ha KS; Park WS; Hong SH; Park JH; Han ET
Korean J Parasitol; 2016 Aug; 54(4):385-91. PubMed ID: 27658588
[TBL] [Abstract][Full Text] [Related]
4. Identification and characterization of Pv50, a novel Plasmodium vivax merozoite surface protein.
Cheng Y; Wang B; Lu F; Ahmed MA; Han JH; Na SH; Ha KS; Park WS; Hong SH; Han ET
Parasit Vectors; 2019 Apr; 12(1):176. PubMed ID: 30999945
[TBL] [Abstract][Full Text] [Related]
5. Immunogenicity of Plasmodium vivax combination subunit vaccine formulated with human compatible adjuvants in mice.
Devi YS; Mukherjee P; Yazdani SS; Shakri AR; Mazumdar S; Pandey S; Chitnis CE; Chauhan VS
Vaccine; 2007 Jul; 25(28):5166-74. PubMed ID: 17544179
[TBL] [Abstract][Full Text] [Related]
6. Plasmodium vivax apical membrane antigen-1: comparative recognition of different domains by antibodies induced during natural human infection.
Múfalo BC; Gentil F; Bargieri DY; Costa FT; Rodrigues MM; Soares IS
Microbes Infect; 2008 Oct; 10(12-13):1266-73. PubMed ID: 18692152
[TBL] [Abstract][Full Text] [Related]
7. Generation, characterization and immunogenicity of a novel chimeric recombinant protein based on Plasmodium vivax AMA-1 and MSP1
Rocha MV; Françoso KS; Lima LC; Camargo TM; Machado RLD; Costa FTM; Rénia L; Nosten F; Russell B; Rodrigues MM; Soares IS
Vaccine; 2017 Apr; 35(18):2463-2472. PubMed ID: 28341111
[TBL] [Abstract][Full Text] [Related]
8. A recombinant vaccine based on domain II of Plasmodium vivax Apical Membrane Antigen 1 induces high antibody titres in mice.
Gentil F; Bargieri DY; Leite JA; Françoso KS; Patricio MB; Espíndola NM; Vaz AJ; Palatnik-de-Sousa CB; Rodrigues MM; Costa FT; Soares IS
Vaccine; 2010 Aug; 28(38):6183-90. PubMed ID: 20654667
[TBL] [Abstract][Full Text] [Related]
9. The Plasmodium vivax Pv41 surface protein: identification and characterization.
Angel DI; Mongui A; Ardila J; Vanegas M; Patarroyo MA
Biochem Biophys Res Commun; 2008 Dec; 377(4):1113-7. PubMed ID: 18983983
[TBL] [Abstract][Full Text] [Related]
10. Clinical expression and antigenic profiles of a Plasmodium vivax vaccine candidate: merozoite surface protein 7 (PvMSP-7).
Cheng CW; Jongwutiwes S; Putaporntip C; Jackson AP
Malar J; 2019 Jun; 18(1):197. PubMed ID: 31196098
[TBL] [Abstract][Full Text] [Related]
11. Antibody response of naturally infected individuals to recombinant Plasmodium vivax apical membrane antigen-1.
Rodrigues MH; Rodrigues KM; Oliveira TR; Cômodo AN; Rodrigues MM; Kocken CH; Thomas AW; Soares IS
Int J Parasitol; 2005 Feb; 35(2):185-92. PubMed ID: 15710439
[TBL] [Abstract][Full Text] [Related]
12. Naturally acquired humoral and cellular immune responses to Plasmodium vivax merozoite surface protein 8 in patients with P. vivax infection.
Cheng Y; Wang B; Changrob S; Han JH; Sattabongkot J; Ha KS; Chootong P; Lu F; Cao J; Nyunt MH; Park WS; Hong SH; Lim CS; Tsuboi T; Han ET
Malar J; 2017 May; 16(1):211. PubMed ID: 28532483
[TBL] [Abstract][Full Text] [Related]
13. Humoral immune responses to a recombinant Plasmodium vivax tryptophan-rich antigen among Plasmodium vivax-infected patients and its localization in the parasite.
Siddiqui AA; Khan F; Sharma YD
Appl Biochem Biotechnol; 2015 Feb; 175(4):2166-77. PubMed ID: 25467946
[TBL] [Abstract][Full Text] [Related]
14. A Library of Plasmodium vivax Recombinant Merozoite Proteins Reveals New Vaccine Candidates and Protein-Protein Interactions.
Hostetler JB; Sharma S; Bartholdson SJ; Wright GJ; Fairhurst RM; Rayner JC
PLoS Negl Trop Dis; 2015 Dec; 9(12):e0004264. PubMed ID: 26701602
[TBL] [Abstract][Full Text] [Related]
15. Immunogenicity and antigenicity of Plasmodium vivax merozoite surface protein 10.
Cheng Y; Wang B; Sattabongkot J; Lim CS; Tsuboi T; Han ET
Parasitol Res; 2014 Jul; 113(7):2559-68. PubMed ID: 24764159
[TBL] [Abstract][Full Text] [Related]
16. Cross-reactivity studies of an anti-Plasmodium vivax apical membrane antigen 1 monoclonal antibody: binding and structural characterisation.
Igonet S; Vulliez-Le Normand B; Faure G; Riottot MM; Kocken CH; Thomas AW; Bentley GA
J Mol Biol; 2007 Mar; 366(5):1523-37. PubMed ID: 17229439
[TBL] [Abstract][Full Text] [Related]
17. Biochemical and immunological characterization of E. coli expressed 42 kDa fragment of Plasmodium vivax and P. cynomolgi bastianelli merozoite surface protein-1.
Kaushal DC; Kaushal NA; Narula A; Kumar N; Puri SK; Dutta S; Lanar DE
Indian J Biochem Biophys; 2007 Dec; 44(6):429-36. PubMed ID: 18320841
[TBL] [Abstract][Full Text] [Related]
18. Immunogenicity of the Plasmodium vivax merozoite surface protein 1 paralog in the induction of naturally acquired antibody and memory B cell responses.
Min HMK; Changrob S; Soe PT; Han JH; Muh F; Lee SK; Chootong P; Han ET
Malar J; 2017 Aug; 16(1):354. PubMed ID: 28854974
[TBL] [Abstract][Full Text] [Related]
19. Immunogenicity of Plasmodium vivax merozoite surface protein-9 recombinant proteins expressed in E. coli.
Oliveira-Ferreira J; Vargas-Serrato E; Barnwell JW; Moreno A; Galinski MR
Vaccine; 2004 May; 22(15-16):2023-30. PubMed ID: 15121316
[TBL] [Abstract][Full Text] [Related]
20. Targeting a Reticulocyte Binding Protein and Duffy Binding Protein to Inhibit Reticulocyte Invasion by Plasmodium vivax.
Gupta S; Singh S; Popovici J; Roesch C; Shakri AR; Guillotte-Blisnick M; Huon C; Menard D; Chitnis CE
Sci Rep; 2018 Jul; 8(1):10511. PubMed ID: 30002416
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
